JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Monday, March 3, 2025

What’s next for COVID-19 vaccines for youngest US children

by

1014 days ago
20220524
FILE - Ilana Diener holds her son, Hudson, 3, during an appointment for a Moderna COVID-19 vaccine trial in Commack, N.Y. on Nov. 30, 2021. Parents hoping to get their youngest children vaccinated against COVID-19 have some encouraging news. Pfizer said Monday, May 23, 2022, that three doses of its vaccines offers strong protection to those under 5. That news comes a month after Moderna said it would ask regulators to OK its two shot regimen for the youngest kids. (AP Photo/Emma H. Tobin, File)

FILE - Ilana Diener holds her son, Hudson, 3, during an appointment for a Moderna COVID-19 vaccine trial in Commack, N.Y. on Nov. 30, 2021. Parents hoping to get their youngest children vaccinated against COVID-19 have some encouraging news. Pfizer said Monday, May 23, 2022, that three doses of its vaccines offers strong protection to those under 5. That news comes a month after Moderna said it would ask regulators to OK its two shot regimen for the youngest kids. (AP Photo/Emma H. Tobin, File)

By The As­so­ci­at­ed Press

 

Par­ents hop­ing to get their youngest chil­dren vac­ci­nat­ed against COVID-19 got some en­cour­ag­ing news Mon­day.

Pfiz­er said three small dos­es of its vac­cine of­fers strong pro­tec­tion to young­sters un­der 5, ac­cord­ing to pre­lim­i­nary da­ta. That news comes a month af­ter Mod­er­na said it would ask reg­u­la­tors to OK its two dos­es tor the youngest kids.

But a few steps re­main be­fore the shots are avail­able. Health of­fi­cials and their ex­pert pan­els must first de­cide they are safe enough and pro­vide enough pro­tec­tion to au­tho­rize them.

FDA RE­VIEW

U.S. Food and Drug Ad­min­is­tra­tion vac­cine chief Dr. Pe­ter Marks has pledged the agency will “move quick­ly with­out sac­ri­fic­ing our stan­dards” in eval­u­at­ing tot-sized dos­es from both Pfiz­er and Mod­er­na.

The FDA has ten­ta­tive­ly set a June 15 date for its sci­en­tif­ic ad­vis­ers to pub­licly re­view the two com­pa­nies’ vac­cines. Af­ter the ad­vis­ers weigh in, the FDA de­ter­mines whether to au­tho­rize the shot.

Mod­er­na is seek­ing clear­ance for two low-dose shots for chil­dren un­der age 6 while Pfiz­er hopes to of­fer three ex­tra-low dos­es to kids un­der age 5 — dif­fer­ences due to how each com­pa­ny stud­ied its vac­cine. Cur­rent­ly the U.S. rec­om­mends vac­ci­na­tions for every­one age 5 and old­er, and Pfiz­er is the on­ly op­tion for those chil­dren. Mod­er­na for now is used on­ly in adults in the U.S.

CDC RE­VIEW

If ei­ther vac­cine is cleared for the lit­tlest kids, the Cen­ters for Dis­ease Con­trol and Pre­ven­tion would have to rec­om­mend whether all ba­bies, tod­dlers and preschool­ers should re­ceive them or on­ly those at high risk of a se­ri­ous ill­ness.

The CDC would con­vene its own pan­el of ad­vis­ers to de­bate the rec­om­men­da­tion be­fore is­su­ing its of­fi­cial guid­ance.

ROLL­OUT

The Biden ad­min­is­tra­tion has said the shots will roll out rapid­ly, and most tots are ex­pect­ed to be vac­ci­nat­ed in pe­di­a­tri­cians’ of­fices or health clin­ics. It’s not clear how much de­mand there will be to vac­ci­nate the youngest kids, how­ev­er. Pfiz­er shots for 5- to 11-year-olds opened in No­vem­ber, but on­ly about 30% of that age group have got­ten the rec­om­mend­ed ini­tial two dos­es.

 

COVID-19COVID-19 casesCovid vaccines


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored